ALL - AL - AK - AZ - AR - CA - CO - CT - DE - FL - GA - HI - ID - IL - IN - IA - KS - KY - LA - ME - MD - MA - MI - MN - MS - MO - MT - NE - NV- NH - NJ - NM - NY - NC- ND - OH - OK - OR - PA - RI - SC - SD - TN - TX - UT - VT - VA - WA - WV - WI - WY

Athersys Biotechnology Company

ATIVESITE | Dr. Ayush Batra discusses the MASTERS-2 clinical trial for the treatment of stroke

ativesite December 7, 2024Last Updated: December 7, 2024

0 Less than a minute

Clip courtesy of Fox32 in Chicago.

Athersys, Inc. is developing MultiStem® cell therapy and is currently in late-stage clinical trials for ischemic stroke, ARDS, and trauma. The MASTERS-2 study is a randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating MultiStem for the treatment of ischemic stroke.

Source Athersys YouTube